r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

SB

Scott L. Burrows

Insider · Chief Financial Officer · SYRE

Scott L. Burrows files insider transactions with the SEC as a chief financial officer of Spyre Therapeutics (SYRE). We hold 9 disclosed purchases and sales filed since 5 April 2021, 5 of them in the last 90 days.

  • Files forSYRE
  • Disclosed buys and sells9 in all, 5 in the last 90 days
  • Last disclosure3 September 2026

Positions held

3 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 22 December 2023 — 2 September 2026Chief Financial Officer · Spyre Therapeutics (SYRE)47 Form 4 lines · source: SEC Form 4
  • Filed 1 September 2023 — 1 September 2023Chief Financial Officer · Aeglea BioTherapeutics (AGLE)1 Form 4 line · source: SEC Form 4
  • Filed 1 April 2021 — 6 March 2023Chief Financial Officer · Arcutis Biotherapeutics (ARQT)16 Form 4 lines · source: SEC Form 4

Everything they disclosed

64 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.